EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,291,907 | -23.4% | 6,159,146 | +3.6% | 0.14% | -24.3% |
| Q2 2023 | $46,060,273 | +40.7% | 5,943,261 | +21.1% | 0.19% | +22.7% |
| Q1 2023 | $32,744,004 | -16.9% | 4,909,146 | +11.3% | 0.15% | -21.8% |
| Q4 2022 | $39,417,765 | -9.1% | 4,409,146 | 0.0% | 0.20% | -1.5% |
| Q3 2022 | $43,386,000 | +99.9% | 4,409,146 | +61.7% | 0.20% | +102.0% |
| Q2 2022 | $21,709,000 | -17.9% | 2,727,249 | 0.0% | 0.10% | -7.5% |
| Q1 2022 | $26,454,000 | -36.5% | 2,727,249 | 0.0% | 0.11% | -10.8% |
| Q4 2021 | $41,672,000 | -8.0% | 2,727,249 | 0.0% | 0.12% | -3.2% |
| Q3 2021 | $45,272,000 | -22.2% | 2,727,249 | 0.0% | 0.12% | -29.5% |
| Q2 2021 | $58,172,000 | -46.6% | 2,727,249 | -18.6% | 0.18% | -45.7% |
| Q1 2021 | $108,948,000 | – | 3,352,249 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |